AWIR OKLAHOMA - Oklahoma City Local Chapter Meeting

Join your AWIR colleagues for an exceptional evening of networking, fine dining, and clinical discussion, hosted by our esteemed local chapter leader, Dr. Latisha Heinlen. Our host will lead the discussion by providing impactful AWIR updates and delivering an educational symposium titled TREMFYA® and IL-17A inhibitors: Evidence from studies of adults with active psoriatic arthritis or moderate to severe plaque psoriasis

Bring your energy and insight as Dr. Heinlen leads an engaging discussion on the interleukin-23 inhibitor TREMFYA®, exploring its mechanism of action, safety, and efficacy in adults with active psoriatic arthritis (PsA) and moderate-to-severe plaque psoriasis (PsO). The presentation will also highlight real-world persistency data comparing TREMFYA® with IL-17 and TNF inhibitors in PsA, as well as head-to-head studies evaluating TREMFYA® versus Cosentyx® (secukinumab) and Taltz® (ixekizumab) in plaque PsO.

Don’t miss this opportunity to engage with experts, expand your knowledge, and connect with fellow professionals in the field. We look forward to an inspiring afternoon of collaboration and professional growth!

Host: Latisha Heinlen, MD

Location: Ranch Steakhouse - 3000 W Britton Rd, Oklahoma City OK

Date: Monday, October 20th 2025

Time: 6:00PM - 8:00PM CST

Registration: Please RSVP by Saturday, October 18th 2025 to reserve your spot!

Click here  to register and join the meeting

Agenda: 

6:00PM Arrival

6:30PM Dinner & Presentation

Educational Symposium

Speaker: Latisha Heinlen, MD

Title: TREMFYA® and IL-17A inhibitors: Evidence from studies of adults with active psoriatic arthritis or moderate to severe plaque psoriasis

Sponsor: Johnson & Johnson

AWIR Topic: Updates

Speaker: Latisha Heinlen, MD

Sponsor: